financetom
Business
financetom
/
Business
/
Newamsterdam Pharma Insider Sold Shares Worth $3,874,017, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Newamsterdam Pharma Insider Sold Shares Worth $3,874,017, According to a Recent SEC Filing
Sep 10, 2025 2:52 PM

05:43 PM EDT, 09/10/2025 (MT Newswires) -- Louise Frederika Kooij, Chief Accounting Officer, on September 09, 2025, sold 150,000 shares in Newamsterdam Pharma ( NAMS ) for $3,874,017. Following the Form 4 filing with the SEC, Kooij has control over a total of 15,000 ordinary shares of the company, with 15,000 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1936258/000095017025114033/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KKR Acquires 25% Stake In Enilive, Supporting Eni's Push For Energy Transition
KKR Acquires 25% Stake In Enilive, Supporting Eni's Push For Energy Transition
Nov 3, 2024
Eni S.p.A. and KKR & Co. Inc. ( KKR ) shares are trading higher on Thursday. KKR agreed to acquire a 25% stake in Enilive for €2.938 billion ($3.172 billion). The transaction includes a €500 million ($540 million) capital increase reserved for KKR and the purchase of €2.438 billion ($2.633 billion) in Enilive shares from Eni. The transaction price values Enilive's total...
European agency offers support for struggling space sector
European agency offers support for struggling space sector
Nov 3, 2024
PARIS, Oct 24 (Reuters) - The European Space Agency unveiled measures on Thursday to speed up payments to the space industry in the face of mounting job cuts, while imposing greater scrutiny following a raft of cost overruns and delays. Director General Josef Aschbacher announced the plan after a council meeting of the 22-nation agency, a week after Airbus announced...
GSK Reports 'Promising Data' From Phase 3 Study of RSV Vaccine Arexvy
GSK Reports 'Promising Data' From Phase 3 Study of RSV Vaccine Arexvy
Nov 3, 2024
09:57 AM EDT, 10/24/2024 (MT Newswires) -- GSK (GSK) reported Thursday that preliminary data from a phase 3 study of its respiratory syncytial virus vaccine Arexvy demonstrated its potential to help protect a larger group of adults at risk from getting RSV. The British pharmaceutical company said the trial, which involved patients between the ages of 18 and 49, could...
ZenaTech Buys Drone Design Patent From Former Parent Company -- Shares Jump Pre-Bell
ZenaTech Buys Drone Design Patent From Former Parent Company -- Shares Jump Pre-Bell
Nov 3, 2024
09:33 AM EDT, 10/24/2024 (MT Newswires) -- ZenaTech ( ZENA ) shares jumped in recent Thursday premarket trading after the software technology company said its ZenaDrone unit is acquiring a US patent for a design related to the second-generation design used in the ZenaDrone 1000 autonomous drone. ZenaTech ( ZENA ) said that the patent was purchased from ZenaTech's (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved